Archives: Agenda
Session Reserved for Technology Showcase Sponsor
Panel Discussion: Forging strong relationships and communication strategies as a clinical supply professional to enhance trial resilience and success
- Breaking down silos to include clinical supply in other departmental discussions earlier
- Bridging the gap between clinical supply, CMC, quality, clinical operations and other stakeholders
- Utilizing robust relationships to be better prepared when running into problems conducting trials
- Increasing the resilience of your trial through succinct collaboration
Reserved for event sponsor
END OF CONFERENCE
Chair’s closing remarks
Session reserved for GlobalData
Designing appropriate and patient-focused oncology trials to reduce patient and site burden
- Understanding site processes and expectations to reduce delays in site initiation, activation, and screening for potential patients
- Championing collaborative sites for a streamlined trial
- Can we ever be appropriately equipped for adverse effects with off-site testing?
PANEL DISCUSSION: How Artificial Intelligence (AI) is powering a new era of cancer drug discovery and development
- Moving from basic functionalities to more meaningful impact and examples of this in practice
- When AI is progressing so quickly, how will regulation evolve to match this speed?
- When is AI not the answer?
- How AI has revolutionised innovative ways of collecting data, biosimulation, and early disease diagnosis for oncology trials
The role of patient research NGOs in drug development – illustrated by the Children’s Tumor
Foundation’s leadership role in the EU PEARL project